• 294 Citations
20082025
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Hematology & Oncology

Training Experience

2010Residency, University of Chicago
2013Fellowship, Stanford University Hospitals

Education/Academic qualification

MD, University of Chicago

… → 2007

Fingerprint Dive into the research topics where Shira Naomi Dinner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Immunoglobulin Light Chains Medicine & Life Sciences
Amyloidosis Medicine & Life Sciences
Hairy Cell Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Leukocyte Count Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2025

Research Output 2008 2019

  • 294 Citations
  • 16 Article
  • 5 Review article
  • 1 Chapter
  • 1 Short survey

Moxetumomab pasudotox for hairy cell leukemia: Preclinical development to FDA approval

Lin, A. Y. & Dinner, S. N., Oct 8 2019, In : Blood Advances. 3, 19, p. 2905-2910 6 p.

Research output: Contribution to journalArticle

Open Access
Drug Approval
Hairy Cell Leukemia
United States Food and Drug Administration
Immunotoxins
Capillary Leak Syndrome

Acute Lymphoblastic Leukemia in Adults

Dinner, S. N., Gurbuxani, S., Jain, N. & Stock, W., Jan 1 2018, Hematology: Basic Principles and Practice. Elsevier Inc, p. 1029-1054.e2

Research output: Chapter in Book/Report/Conference proceedingChapter

Precursor Cell Lymphoblastic Leukemia-Lymphoma
32 Citations (Scopus)

Adolescent and young adult oncology, version 2.2018: Clinical practice guidelines in oncology

Coccia, P. F., Pappo, A. S., Beaupin, L., Borges, V. F., Borinstein, S. C., Chugh, R., Dinner, S., Folbrecht, J., Frazier, A. L., Goldsby, R., Gubin, A., Hayashi, R., Huang, M. S., Link, M. P., Livingston, J. A., Matloub, Y., Millard, F., Oeffinger, K. C., Puccetti, D., Reed, D. & 10 others, Robinson, S., Rosenberg, A. R., Sanft, T., Spraker-Perlman, H. L., Von Mehren, M., Wechsler, D. S., Whelan, K. F., Yeager, N., Gurski, L. A. & Shead, D. A., Jan 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 1, p. 66-97 32 p.

Research output: Contribution to journalReview article

Practice Guidelines
Young Adult
Guidelines
Fertility
Counseling

Antibody-based therapies in patients with acute lymphoblastic leukemia

Dinner, S. N. & Liedtke, M., Nov 30 2018, In : Hematology. 2018, 1, p. 9-15 7 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Antibodies
Residual Neoplasm
Therapeutics
Immunotherapy

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Dinner, S. N., Dunn, T. J., Price, E., Coutré, S. E., Gotlib, J., Berube, C., Kaufman, G. P., Medeiros, B. C. & Liedtke, M., Sep 1 2018, In : International journal of hematology. 108, 3, p. 267-273 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maximum Tolerated Dose
Anthracyclines
Dizziness